Andere Sprachen Lipidor AB

Aktien

A2PHEZ

SE0012558617

LIPI

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:24:19 03.05.2024			% 5 Tage	% 1. Jan.
0,231 ^SEK	-4,94 %		+0,43 %	-54,17 %

22.04.	Lipidor AB (publ) verschiebt die Veröffentlichung des Geschäftsberichts für 2023	CI
21.03.	Lipidor AB (publ) gibt die Genehmigung für den Start der klinischen Phase III-Studie mit dem Psoriasis-Kandidaten AKP02G2 bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Lipidor AB announces new date for publication of Annual Report 2023	22.04.
Lipidor AB Postpones the Publication of Annual Report for 2023	22.04.
NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)	10.04.
Lipidor resolves on a rights issue of approximately SEK 58.0 million and enters into a co-investment agreement which secures funding for the implementation of the upcoming phase III study	10.04.
Lipidor completes planned divestment of shares in Emollivet	26.03.
Lipidor announces approval for start of Phase III clinical trial of psoriasis candidate AKP02G2	21.03.
Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2	21.03.
Lipidor adds capital through sale of shares	06.03.
Lipidor AB (publ) publishes year-end report for 2023	28.02.
Lipidor AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28.02.
Lipidor completes SEK 1.7 million sale of animal segment patent	24.01.
Lipidor adds 1.1 MSEK through sale of shares in associated company and agreement of loan	21.12.
Lipidor Seeks Approval for Late-stage Study of Plaque Psoriasis Medicine in India	20.12.
Lipidor applies to the Indian Medical Products Agency to start a Phase III study of AKP02G2	20.12.
Lipidor Applies to the Indian Medical Products Agency to Start A Phase III study of AKP02G2	20.12.
Lipidor presents Nomination Committee	05.12.
Lipidor changes Certified Adviser to Carnegie Investment Bank AB (publ)	30.11.
Lipidor AB (publ) publishes interim report for Q3 2023	22.11.
Lipidor AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22.11.
Lipidor Files New Patent Application for Akvano Technology in EU	27.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Lipidor AB

Aktien

A2PHEZ

SE0012558617

LIPI

Andere Sprachen

Filter